Search Within

Advanced Practice Providers

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (7)
Groups
  1. Department of Medicine (18)
  2. Sarcoma Service (18)
  3. Solid Tumor Oncology Division (18)
  4. Nursing (17)
  5. Biostatistics Service (6)
  6. Epidemiology and Biostatistics (6)

More Groups

People
  1. Mark Dickson (12)
  2. Gary Schwartz (9)
  3. Richard Carvajal (7)
  4. Heather Dials (6)
  5. Sandra D'Angelo (5)
  6. Lauren Cane (4)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (1)
  5. 2020 (1)
  6. 2016 (1)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Annals of Oncology (1)
  3. Blood (1)
  4. Cancer (1)
  5. Cancer Chemotherapy and Pharmacology (1)
  6. Cancer Immunology Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Oxford University Press (2)
  3. Springer (2)
  4. American Association for Cancer Research (1)
  5. American Society of Hematology (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Khan, S. A.; Callahan, M.; Postow, M. A.; Chapman, P. B.; Schwartz, G. K.; Dickson, M. A.; D'Angelo, S. P.; Luke, J. J.; Bluth, M. J.; Roman, R. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations
    Meeting Abstract

    D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors
    Journal Article

    Dickson, M. A.; Rathkopf, D. E.; Carvajal, R. D.; Grant, S.; Roberts, J. D.; Reid, J. M.; Ames, M. M.; McGovern, R. M.; Lefkowitz, R. A.; Gonen, M.; more...
    Investigational New Drugs (2011)

    Fulltext@MSK | Save
  • Phase Ib study of PTC299, a novel oral inhibitor of tumor VEGF expression, in patients with advanced cancer
    Meeting Abstract

    Schwartz, G. K.; Dickson, M. A.; Callahan, L. A.; Darby, C. H.; Llorente, M.; Cao, Y.; Dials, H. J.; Miller, L. L.; Miao, H. H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I trial of pulse-dose vorinostat with flavopiridol in solid tumors
    Meeting Abstract

    Dickson, M. A.; Rathkopf, D. E.; Grant, S.; Roberts, J. D.; Reid, J. M.; Ames, M. M.; McGovern, R. M.; Gonen, M.; Dials, H. J.; Schwartz, G. K.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pancyclin-dependentkinase (CDK) inhibitor flavopiridol
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M.; Tse, A. N.; Dials, H.; Cane, L. M.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I study of FOLFOX administered with flavopiridol (F) in patients with refractory solid tumors
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M. A.; Cane, L. M.; Dials, H. J.; Schwartz, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save